Holen Sie sich die Stockscreener-App
41.39
1.31%
-0.55
Schlusskurs vom Vortag:
$41.94
Offen:
$42.11
24-Stunden-Volumen:
444.37K
Marktkapitalisierung:
$2.26B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.99M
KGV:
-12.32
EPS:
-3.36
Netto-Cashflow:
$-92.18M
1W Leistung:
+0.17%
1M Leistung:
+3.45%
6M Leistung:
+202.34%
1J Leistung:
+445.32%
1-Tages-Spanne:
$40.92
$42.26
52-Wochen-Spanne:
$7.10
$50.78
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
170 Harbor Way, 3rd Floor, South San Francisco
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say - MSN
MSN
Vera Therapeutics executive trades shares worth over $1.3 million - Investing.com Australia
Investing.com Australia
Vera Therapeutics executive trades shares worth over $1.3 million - Investing.com India
Investing.com India
Vera Therapeutics executive trades shares worth over $1.3 million - Investing.com
Investing.com
New York State Common Retirement Fund Increases Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Defense World
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Vera Therapeutics Inc (VERA) Nettogewinn 2024
VERA betrug am 2023-12-31 der Nettogewinn der letzten 12 Monate -95.99 Millionen US-Dollar, was einem Rückgang von -7.79% im Vergleich zum Vorjahr entspricht.
Vera Therapeutics Inc (VERA) Free Cashflow 2024
VERA verzeichnete einen Free Cashflow der letzten 12 Monate von -92.18 Millionen US-Dollar für das Quartal bis zum 2023-12-31, was einem Rückgang von -36.25% im Vergleich zum Vorjahr entspricht.
Vera Therapeutics Inc (VERA) Gewinn je Aktie 2024
Der Gewinn je Aktie (EPS) von VERA für die letzten 12 Monate betrug -2.29 US-Dollar für das Quartal, das am 2023-12-31 endete, was einem Wachstum von +31.85% im Vergleich zum Vorjahr entspricht.
Vera Therapeutics Inc-Aktie (VERA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
May 16 '24 |
Sale |
42.32 |
20,651 |
873,890 |
51,206 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
May 15 '24 |
Option Exercise |
3.94 |
8,221 |
32,387 |
61,392 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
May 15 '24 |
Sale |
42.27 |
10,186 |
430,546 |
51,206 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
Apr 10 '24 |
Sale |
40.00 |
5,714 |
228,560 |
53,171 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Apr 03 '24 |
Option Exercise |
14.87 |
99,828 |
1,484,442 |
166,165 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Apr 03 '24 |
Sale |
39.61 |
99,828 |
3,954,516 |
66,337 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Apr 03 '24 |
Sale |
39.42 |
18,649 |
735,205 |
0 |
| Katabi Maha | Director |
Mar 25 '24 |
Sale |
40.50 |
340,000 |
13,770,000 |
2,793,987 |
| Katabi Maha | Director |
Mar 22 '24 |
Sale |
40.51 |
413,450 |
16,748,860 |
3,133,987 |
| Katabi Maha | Director |
Mar 21 '24 |
Sale |
44.20 |
81,009 |
3,580,723 |
3,547,437 |
0.77%
1.20%
Kapitalisierung:
|
Volumen (24h):